Originally from Costa Rica, and trained as a physician, she is now dedicated to cardiovascular disease research and education, mainly in the fields of prevention, imagining, percutaneous valve replacement and fibromuscular dysplasia.

Before joining Texas Heart Institute, she worked at the pediatric surgery department dedicated to treating burn victims at the National Children’s Hospital in Costa Rica and other central America countries, eventually bringing her to Houston’s Shriners Hospital for Children for further experience. Through her work with Shriners Hospital, she was exposed to exceptional treatment programs that motivated her to get involve with longitudinal outcome assessments, outreach clinics in areas with minorities, and investigations into techniques to improve population outcomes.

After the six years as a fellow of Cardiovascular Disease Research and Women’s Heart Health program at Texas Heart Institute, she joined the Women’s Center at THI. She is active in multiple research projects, including projects on echocardiography, structural heart disease, percutaneous valve replacement, coronary artery anomalies, the relationship between depression and cardiovascular disease, fibromuscular dysplasia, women’s preventive medicine, and the development of digital educational materials. She oversees the Houston Heart Reach Registry (HHR), the Percutaneous Valve Registry and the FMD Clinic and Registry.

Her outstanding contribution to research has been influenced by her roots and interactions with the Spanish-speaking community. Through the Houston HeartReach project, she works with prestigious organizations such as nationally recognized UT Health Science Center, Baylor College of Medicine, Women Heart National Hospital Alliance, ExxonMobil, FitHouston, American Heart Association, Elnita McClain Women’s Center, LHI Houston, BakerRipley, Breakthrough Houston, Girl Scouts, and Houston ISD, which are dedicated to eliminating barriers to healthcare and promoting health and wellness. Since the launch of the HoustonHeart Reach bilingual study and registry, Dr. Campos has enrolled and screened over 1600 women in the program.

Dr. Campos currently manages the Percutaneous Valve Replacement Registry, the Houston Heart Reach Registry, the Fibromuscular Dysplasia Registry associated to the North American Registry for Fibromuscular Dysplasia, collaborates with the Women’s Center Clinical Trials and supports clinical education by serving as a supervisor for The Texas Heart Institute Cardiovascular Disease Fellowship at Baylor St. Luke’s Medical Center.

“Is our responsibility not only to treat and prevent the existing disease but to actively research to uncover new treatments, develop preventive strategies and make lifestyle changes. Having the opportunity to make a difference is an experience I will cherish forever” says Dr Campos.